Up to 450% mark-up on knee implants, govt may cap prices

  • News
  • August 15, 2017

New Delhi :  Just like stents, the National Pharmaceutical Pricing Authority (NPPA) has revealed the unrealistic trade margins enjoyed by sellers of orthopaedic (knee) implants medical devices . According to the analysis done by the NPPA, the average trade margins on some of the devices used in knee implants are as high as 449 per cent. The total trade margin on five implant components used in the knee range between 211 per cent and 449 per cent. As a result, an insert, which has a landed price of ₹14,071 finally costs the patient ₹1.03 lakh – 449 per cent higher, a price sheet from the NPPA showed. A similar exercise conducted by the Authority before bringing the prices of coronary stents under strict price control, which had shown that between the pharmaceutical company and the patient, trade margins of as much as 1026 per cent were added to the life-saving devices. As a result of which, a stent with a landed cost of about₹40,820 could finally burn a hole worth ₹1.98 lakh in the patient’s pocket. The Authority had finally capped the prices of stents in February, decreasing the maximum retail price by 80 per cent for some devices. It is estimated that over two lakh replacement surgeries are conducted in India and the market is growing at an estimated 26-30 per cent annually.

  • Related Posts

    ‘A Knight in Shining Armor’ packed a punch in FOGSI for Gender Equality

    New Delhi: There was no fog in sight; FOGSI was shining as never before, thanks to the leadership of its outgoing president Dr Hrishikesh Pai. The over 40, 000 strong…

    • News
    • December 16, 2023
    • 7 views
    Women are on Trajectory to make Presence Felt in Healthcare India

    New Delhi: It could be advantage patients in times to come as women as workforce are increasing in healthcare domain of India. It is given that women power blended with…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down